Isabella Bank Corporation 10-Q Summary
Business Context and Reporting Period
Isabella Bank Corporation, a Michigan-based bank holding company, reported unaudited results for the three months ended March 31, 2020. Its banking business serves primarily central Michigan through commercial, agricultural, residential real estate, and consumer lending, along with deposit, mortgage, investment, and trust services. The filing reflects the initial financial effects and uncertainties associated with the COVID-19 pandemic.
Key Financial Metrics
| Metric | Q1 2020 | Q1 2019 | Change |
|---|---|---|---|
| Total interest income | $16.201 million | $16.481 million | Down $0.280 million |
| Net interest income | $12.002 million | $12.189 million | Down $0.187 million |
| Provision for loan losses | $0.788 million | $0.034 million | Up $0.754 million |
| Noninterest income | $2.998 million | $2.490 million | Up $0.508 million |
| Noninterest expenses | $10.945 million | $10.800 million | Up $0.145 million |
| Net income | $3.064 million | $3.496 million | Down 12.4% |
| Diluted earnings per share | $0.38 | $0.43 | Down $0.05 |
| Cash dividends per share | $0.27 | $0.26 | Up $0.01 |
| Net interest margin, FTE | 2.98% | 3.02% | Down 4 basis points |
| Return on average assets | 0.68% | 0.77% | Down 9 basis points |
| Return on average equity | 5.68% | 7.00% | Down 132 basis points |
At March 31, 2020, total assets were $1.816 billion, gross loans were $1.176 billion, deposits were $1.322 billion, borrowed funds were $263.2 million, and shareholders’ equity was $215.5 million. Gross loans declined 0.9% from December 31, 2019, mainly because agricultural loans fell 6.9%; residential real estate loans increased 1.2%.
Cash and cash equivalents increased to $96.8 million from $60.6 million at year-end. Primary liquidity, consisting of cash and unencumbered available-for-sale securities, was $310.6 million, or 17.1% of assets. The company reported total cash and liquidity of approximately $406.9 million, including $140.1 million of available lines of credit and an estimated $170.0 million of unencumbered lendable collateral.
Net cash provided by operating activities was $3.4 million. Investing activities provided $40.0 million, primarily reflecting net loan collections, sales and maturities of available-for-sale securities, and proceeds from life insurance redemptions. Financing activities used $7.2 million. Cash and cash equivalents increased $36.2 million during the quarter.
The allowance for loan and lease losses increased to $8.7 million from $7.9 million, equal to 0.74% of gross loans versus 0.67% at year-end. Nonperforming loans were $7.0 million, or 0.59% of gross loans, and nonperforming assets were $7.7 million, or 0.43% of total assets.
Capital remained strong. The bank’s March 31 regulatory ratios were 12.72% common equity tier 1, 12.72% Tier 1 risk-based capital, 13.41% total risk-based capital, and 9.09% Tier 1 leverage, exceeding “well capitalized” thresholds.
Material Changes Versus Prior Comparable Period
- Net income declined $432,000, or 12.4%, primarily because of lower net interest income and a substantially higher loan-loss provision.
- Net interest income declined 1.5%, while the FTE net interest margin decreased to 2.98% from 3.02% because of lower market interest rates and a flat yield curve.
- The loan-loss provision increased more than twentyfold to $788,000 as management incorporated higher economic and credit risks associated primarily with COVID-19 and increased impaired-loan reserves.
- Noninterest income increased 20.4%, mainly due to a $524,000 gain from the redemption of a corporate-owned life insurance policy and a $71,000 gain on available-for-sale securities. This was partly offset by lower investment and trust advisory fees and a $245,000 mortgage servicing rights impairment.
- Available-for-sale securities declined $22.7 million from year-end to $407.2 million after $26.9 million of securities sales. Unrealized gains increased, contributing $4.7 million of other comprehensive income and lifting accumulated other comprehensive income to $6.7 million.
- Deposits increased $8.2 million, while borrowed funds declined $12.8 million. Shareholders’ equity increased $5.3 million.
- Total past-due and nonaccrual loans increased to $14.8 million from $11.4 million at year-end, although management attributed the increase primarily to deterioration in a small number of commercial loans rather than COVID-19.
Guidance, Outlook, Commentary, Risks, and Unusual Items
- Management expects commercial loan growth during the remainder of 2020 from participation in the Small Business Administration Paycheck Protection Program, while residential real estate and consumer lending are also expected to grow. Agricultural lending had declined during the quarter and over the preceding year.
- Management stated that improvement in net interest yield may be gradual or may not occur during the remainder of 2020 because of the low-rate environment, yield-curve pressure, and economic uncertainty.
- The company began offering short-term payment relief, generally allowing eligible borrowers in good standing as of March 1, 2020 to defer full or partial payments for 90 days. Regulators indicated that qualifying COVID-19 modifications would not be treated as troubled debt restructurings.
- The CARES Act and PPP were enacted or became operational after quarter-end. The filing does not provide a clear amount of PPP loans originated or expected fee income as of March 31, 2020.
- Management cannot estimate the ongoing financial impact of COVID-19. Risks include borrower payment deferrals, unemployment, business closures, delayed recognition of credit deterioration, higher credit losses, deposit-flow changes, interest-rate and prepayment volatility, liquidity needs, cybersecurity, vendor, and operational risks.
- The company adopted a delayed implementation date of January 1, 2023 for the current expected credit loss standard and does not plan to adopt early. Management expects the standard could significantly affect results and disclosures.
- The company repurchased 59,420 shares for $1.168 million during the quarter and had authorization to repurchase an additional 188,486 shares at March 31, 2020.
- No material legal proceedings were reported, and management concluded that disclosure controls and procedures were effective as of March 31, 2020.
Most Important Facts for Investors to Verify
- Subsequent-quarter PPP loan balances, related fee income, forgiveness activity, and associated funding costs.
- Borrower payment deferrals, criticized and classified loans, nonaccrual loans, charge-offs, and required allowance increases as COVID-19 effects develop.
- Changes in net interest margin, deposit pricing, loan yields, securities balances, and borrowing levels in the low-rate environment.
- Whether the unusual $524,000 life-insurance redemption gain and $71,000 securities gain recur.
- Investment and trust asset levels and fee income following the market decline.
- Liquidity availability, collateral requirements, deposit stability, and the continued use of FHLB advances and other borrowings.
- The effect of payment deferrals and regulatory relief on the timing and visibility of credit deterioration.
- Future adoption planning and estimated balance-sheet and earnings effects of the CECL standard.